[go: up one dir, main page]

FR2585705B1 - Sels de cephalosporine et compositions injectables - Google Patents

Sels de cephalosporine et compositions injectables

Info

Publication number
FR2585705B1
FR2585705B1 FR8610892A FR8610892A FR2585705B1 FR 2585705 B1 FR2585705 B1 FR 2585705B1 FR 8610892 A FR8610892 A FR 8610892A FR 8610892 A FR8610892 A FR 8610892A FR 2585705 B1 FR2585705 B1 FR 2585705B1
Authority
FR
France
Prior art keywords
injectable compositions
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8610892A
Other languages
English (en)
Other versions
FR2585705A1 (fr
Inventor
Murray A Kaplan
Thomas W Hudyma
Robert A Lipper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2585705A1 publication Critical patent/FR2585705A1/fr
Application granted granted Critical
Publication of FR2585705B1 publication Critical patent/FR2585705B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8610892A 1985-08-05 1986-07-28 Sels de cephalosporine et compositions injectables Expired FR2585705B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (2)

Publication Number Publication Date
FR2585705A1 FR2585705A1 (fr) 1987-02-06
FR2585705B1 true FR2585705B1 (fr) 1989-01-13

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8610892A Expired FR2585705B1 (fr) 1985-08-05 1986-07-28 Sels de cephalosporine et compositions injectables

Country Status (34)

Country Link
JP (1) JPH0615548B2 (fr)
KR (1) KR930003121B1 (fr)
AR (1) AR243894A1 (fr)
AT (1) AT390957B (fr)
AU (1) AU597262B2 (fr)
BE (1) BE905219A (fr)
CA (1) CA1284994C (fr)
CH (1) CH675581A5 (fr)
CS (2) CS276717B6 (fr)
CY (1) CY1614A (fr)
DD (2) DD254941A5 (fr)
DE (1) DE3626375A1 (fr)
DK (1) DK162053C (fr)
EG (1) EG18003A (fr)
ES (1) ES2002112A6 (fr)
FI (1) FI84484C (fr)
FR (1) FR2585705B1 (fr)
GB (1) GB2179936B (fr)
GR (1) GR862055B (fr)
HK (1) HK99691A (fr)
HU (1) HU196602B (fr)
IE (1) IE59222B1 (fr)
IL (1) IL79608A (fr)
IT (1) IT1197067B (fr)
LU (2) LU86540A1 (fr)
MY (1) MY102212A (fr)
NL (1) NL8601991A (fr)
OA (1) OA08672A (fr)
PT (1) PT83134B (fr)
SE (1) SE469633B (fr)
SG (1) SG79791G (fr)
SU (1) SU1516013A3 (fr)
YU (1) YU45793B (fr)
ZA (1) ZA865842B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
KR950010084B1 (ko) * 1987-06-25 1995-09-06 반유세이야꾸 가부시끼가이샤 결정성 세팔로스포린 화합물, 그의 제조법 및 그의 제조 중간체
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
EP0638573A1 (fr) * 1993-08-10 1995-02-15 Lucky Ltd. Hydrates crystallins d'une céphalosporine et procédé pour leur préparation
US7592447B2 (en) 2003-12-23 2009-09-22 Sandoz Ag Process for production of intermediates for use in cefalosporin synthesis
WO2008056221A2 (fr) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Sel de sulfate cristallin d'antibiotique céphalosporine
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (fr) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporines
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
HK99691A (en) 1991-12-13
EG18003A (en) 1991-08-30
GR862055B (en) 1986-12-24
CS276717B6 (en) 1992-08-12
AU6069486A (en) 1987-02-12
CS276849B6 (en) 1992-08-12
IE862078L (en) 1987-02-05
IE59222B1 (en) 1994-01-26
ZA865842B (en) 1987-04-29
SE469633B (sv) 1993-08-09
YU137186A (en) 1987-12-31
PT83134B (pt) 1989-07-31
SG79791G (en) 1991-11-15
LU86540A1 (fr) 1987-03-06
ATA211086A (de) 1990-01-15
FI84484B (fi) 1991-08-30
ES2002112A6 (es) 1988-07-16
AU597262B2 (en) 1990-05-31
GB2179936B (en) 1989-04-26
KR880002530A (ko) 1988-05-09
FI863155A0 (fi) 1986-08-01
PT83134A (en) 1986-09-01
DD254941A5 (de) 1988-03-16
HU196602B (en) 1988-12-28
IT1197067B (it) 1988-11-25
DE3626375A1 (de) 1987-02-12
FI84484C (fi) 1991-12-10
IT8621409A1 (it) 1988-02-04
MY102212A (en) 1992-05-15
BE905219A (fr) 1987-02-04
IL79608A0 (en) 1986-11-30
CA1284994C (fr) 1991-06-18
AR243894A1 (es) 1993-09-30
CY1614A (en) 1992-07-10
FR2585705A1 (fr) 1987-02-06
SE8603308D0 (sv) 1986-08-04
DK162053C (da) 1992-02-10
GB2179936A (en) 1987-03-18
DK371886A (da) 1987-02-06
OA08672A (en) 1989-03-31
AT390957B (de) 1990-07-25
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
DK162053B (da) 1991-09-09
IT8621409A0 (it) 1986-08-04
SU1516013A3 (ru) 1989-10-15
FI863155A (fi) 1987-02-06
YU45793B (sh) 1992-07-20
JPS62103090A (ja) 1987-05-13
DK371886D0 (da) 1986-08-04
NL8601991A (nl) 1987-03-02
GB8618989D0 (en) 1986-09-17
JPH0615548B2 (ja) 1994-03-02
CH675581A5 (fr) 1990-10-15
DD268395A5 (de) 1989-05-31
HUT41802A (en) 1987-05-28
LU88574I2 (fr) 1995-03-01
IL79608A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
DK106786D0 (da) Heterocycliske forbindelser
DK521589A (da) Cyclopropyl-substituerede dialkyl-forbindelser med insekticid virkning
ZA89407B (en) Cephalosporin salts and injectable compositions
FR2585705B1 (fr) Sels de cephalosporine et compositions injectables
DK496086A (da) Heterocykliske forbindelser
DK219986A (da) Nitrogenholdige heterocycliske forbindelser
MC1729A1 (fr) Sels polycycliques
KR890700128A (ko) 세팔로스포린 유도체
IT8548071A1 (it) Cefalosporina alogenidrato cristallino
IT1200125B (it) Composti di cefalosporina e procedimento per produrli
PH23442A (en) Cephalosporin derivatives and salts thereof
DK166385D0 (da) Cephalosporinderivater samt salte deraf
DK397686A (da) Heterocycliske forbindelser
DK109586A (da) Heterocycliske forbindelser
DK414886D0 (da) Substituerede heterocycliske forbindelser
PH21201A (en) Cephalosporin derivatives and salts thereof
IL88959A (en) Cephalosporin salts and injectable compositions
DK577286A (da) Cephalosporinderivater
RO92098A2 (fr) Composition additive
DK422085D0 (da) Heterocycliske forbindelser
LV5743A4 (lv) Heterocikliskie savienojumi
DK280485D0 (da) Forskydeligt tremmegitter
DK271286A (da) Antibakterielt virksomme forbindelser

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: CEFEPIME HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: NL 18323 19930727; FIRST REGISTRATION:

Spc suppl protection certif: 93C0068

Filing date: 19931223

CD Change of name or company name
CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: BO 44/94 PAGE 209:LIRE 2585705 AU LIEU DE 2586705

CP Supplementary protection certificate (spc) filed